Cormark Securities and ATB Cap Markets boost STERIS' stock rating, signaling a positive outlook for the healthcare firm.

Cormark Securities and Atb Cap Markets have upgraded STERIS' stock rating to "Moderate Buy" and "Strong Buy" respectively, indicating positive outlooks for the healthcare and life science solutions provider. STERIS aims to enhance global health and safety through its innovative products and services. Investors can stay updated with MarketBeat.com's free daily newsletter for news and ratings on STERIS and similar companies.

3 months ago
3 Articles

Further Reading